Total Debt
—
Net Debt
-$10.5M
Greenwich LifeSciences, Inc. currently has — in total debt. Net debt is -$10.5M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
GLSI • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2025-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2025-09-30 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 0.0% |
| 2025-06-30 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 0.0% |
| 2025-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 0.0% |
| 2024-12-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 0.0% |
| 2024-09-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2024-06-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2024-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2023-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2023-09-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2023-06-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2023-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2022-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 0.0% |
| 2022-09-30 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |
| 2022-06-30 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |
| 2022-03-31 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 0.0% |
| 2021-12-31 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 0.0% |
| 2021-09-30 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 0.0% |
| 2021-06-30 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 0.0% |
| 2021-03-31 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 0.0% |
| 2020-12-31 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 1.0% |
| 2020-09-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 10.1% |
| 2020-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 226.3% |
| 2020-03-31 | 0.00 | 0.00 | 0.00 | 0.00 | 2464.7% |
| 2019-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | 2381.4% |
| 2019-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | — |
| 2018-12-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 0.0% |